UCB, a global biopharmaceutical company, today announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage biotechnology ...
Three Iranian men pressed rehydrated raisins at an artisan distillery just outside New York, thousands of miles from their ...